Unleashing the value of point-of-care cell and gene therapies requires a diverse set of scientific, clinical and engineering expertise.  

We’ve assembled a team of innovators and executive leaders with decades of experience developing and bringing to market advanced cell and gene therapies using integrated combination device systems.  

Each member of our team has played a crucial role in developing peripheral blood collection & processing technology and immunology & oncology cell therapies over the last three decades. 

Nipon Das, M.D.
CEO & Co-Founder
David Peritt, PhD.
Chief Scientific Advisor &
Dennis Briggs
Engineering Advisor
Mark Popovsky, M.D.
Clinical & Medical Advisor
Denise Oppermann
Regulatory Advisor

© 2019 by Lupagen